Sagent Pharmaceuticals Inc - SGNT - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Sagent Pharmaceuticals Inc - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
SGNT	Nasdaq	2834	http://www.sagentpharma.com	17.09 +0.47
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Sagent Pharmaceuticals Inc China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million - May 12th, 2013 1:54 am SAGENT PHARMACEUTICALS, INC. Financials - May 11th, 2013 11:04 am Q1 2013 SAGENT Pharmaceuticals Inc Earnings Release - Before Market Open - May 6th, 2013 5:07 am Sagent Pharmaceuticals Reports First Quarter 2013 Financial Results - May 6th, 2013 5:00 am Sagent Pharmaceuticals Announces Agreement to Acquire Remaining 50% Interest in Chinese Manufacturing Joint Venture - May 6th, 2013 5:00 am SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations an - May 5th, 2013 11:01 pm Wall Street Transcript Interview with David Amsellem, Managing Director and Senior Research Analyst at Piper Jaffray & Co.: Alternative Dosage Forms Create Barriers Against Competition in Generics - May 2nd, 2013 9:07 am Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2013 Financial Results - Apr 24th, 2013 6:00 am 3 Biggest Biotech Crashes This Month - Mar 31st, 2013 11:30 am Follow The Crashing Biotechs: 4 Stocks Fresh From A Fall - Mar 20th, 2013 1:03 pm SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial S - Mar 19th, 2013 9:03 pm Sagent Pharmaceuticals Appoints James M. Hussey as President - Mar 19th, 2013 4:51 pm Sagent Pharmaceuticals Appoints James M. Hussey as President - Mar 19th, 2013 3:36 pm SAGENT PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report - Mar 18th, 2013 7:32 am This Week in Biotech - Mar 16th, 2013 10:00 am Picking Up the Pieces of Shattered Spectrum - Mar 14th, 2013 4:33 pm Has Spectrum Pharmaceuticals Become the Perfect Stock? - Mar 14th, 2013 8:36 am Spectrum shares plunge as hospitals switch to cheaper colon cancer treatment - Mar 13th, 2013 11:44 am Spectrum Pharma Stock Plunges After Guidance Whacked - Mar 13th, 2013 8:50 am Down 35%! This Is a Biotech Trainwreck - Mar 13th, 2013 8:06 am View All Current Headlines >>